Skip Navigation

Digestive Diseases Statistics Clinical Trials Awareness and Prevention Series
Celiac Disease Awareness Campaign Resources Order About NDDIC Información en Español
dots
A to Z list of Digestive Diseases Easy-to-Read Publications Spanish-language Publications Awareness and Prevention Series
Email to a friend  Email to a friend icon
Print this page    Print this page icon
Home : About NDDIC : NDDIC News : Fall 2009
 

Digestive Diseases News
Fall 2009

Study Finds Low Short-term Risks after Bariatric Surgery for Extreme Obesity

Photograph of an obese man’s midsection.

Rates of short-term complications, including death, were low after bariatric surgery among participants in the Longitudinal Assessment of Bariatric Surgery (LABS-1), a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Investigators followed 4,776 patients who had bariatric surgery, evaluating complications and death rates within the first 30 days after surgery.

“There is a real need to determine safe and effective treatments for patients with extreme obesity and its associated medical conditions,” said Susan Z. Yanovski, M.D., co-director of the NIDDK Office of Obesity Research and a co-author of the July 30 The New England Journal of Medicine report about the study. “This study’s results can help patients and physicians make informed decisions about potential risks and benefits of bariatric surgery.”

Patients were at least 18 years old and had an average body mass index (BMI) of 44, considered extremely obese. BMI measures weight in relation to height. As with most populations undergoing bariatric surgery, the majority of LABS-1 patients were Caucasian and female. The study took place over 2 years at 10 medical sites, with one additional center coordinating data collection and analyses.

Research centers participating in the National Institute of Diabetes and Digestive and Kidney Diseases-funded Longitudinal Assessment of Bariatric Surgery study include
  • Columbia University Medical Center, New York
  • Cornell University Medical Center, New York
  • East Carolina Medical Center, Greenville, NC
  • Legacy Good Samaritan Hospital, Portland, OR
  • Neuropsychiatric Research Institute, Fargo, ND
  • Oregon Health & Science University, Portland
  • Sacramento Bariatric Medical Associates, Sacramento, CA
  • University of Pittsburgh Graduate School of Public Health (Data Coordinating Center)
  • University of Pittsburgh Medical Center
  • University of Washington, Seattle
  • Virginia Mason Medical Center, Seattle

Obesity Surgery

Bariatric surgery helps people with extreme obesity lose weight by limiting food intake, nutrient absorption, or both. Currently, more than one-third of U.S. adults have a BMI greater than 30, considered obese, and an increasing number surpass a BMI of 40, considered extremely obese. People who are extremely obese are potential candidates for bariatric surgery. People with BMIs less than 40 are also considered for surgery if they have medical complications related to obesity.

Participants in LABS-1 underwent adjustable gastric banding or Roux-en-Y gastric bypass, which was performed through either minimally invasive laparoscopic surgery or open surgery. Gastric banding creates a pouch around the top of the stomach to limit food intake at any one time. Roux-en-Y gastric bypass also creates a pouch, but it also redirects food around most of the stomach and part of the small intestine, limiting the absorption of food.

Bariatric surgery can have dramatic health benefits, such as improved blood sugar control or even reversal of type 2 diabetes. But it also carries serious risks, including death. The LABS-1 study aimed to evaluate the short-term safety of bariatric surgery to help doctors and patients understand the risks.

Short-term Risks

LABS-1 found that within 30 days of surgery, 4.1 percent of patients had at least one major adverse outcome, defined as death, development of blood clots in the deep veins of the legs or in the pulmonary artery of the lungs, repeat surgeries, or failure to be discharged from the hospital within 30 days of surgery.

Thirty-day mortality was low, ranging from no deaths in the laparoscopic adjustable gastric band group, to six (0.2 percent) in the laparoscopic Roux-en-Y gastric bypass group, to nine (2.1 percent) in those undergoing open Roux-en-Y gastric bypass. The overall risk of complications also varied by procedure.

The investigators pointed out, however, that people who underwent some procedures, such as open Roux-en-Y gastric bypass, tended to be heavier and sicker than those who underwent laparoscopic adjustable gastric banding.

After adjusting for patient and center characteristics, the investigators found no significant differences in complication risk that could be attributed to the type of procedure. Some patient factors, however, increased the risk of complications, including a preoperative history of deep vein blood clots and sleep apnea. Patients with a very high BMI were also at increased risk—those with a BMI of 75 had a 61 percent higher risk of complications than those with a BMI of 53.

Longitudinal Assessment

LABS-1 is part of the LABS consortium, an NIDDK-funded study launched in 2003 to examine the short- and long-term benefits and risks of bariatric surgery for adults with extreme obesity. LABS-2 will follow a subset of LABS-1 patients to gather longer-term information on patient characteristics, types of surgeries, medical and psychosocial outcomes, and economic factors.

The LABS consortium brings together researchers with expertise in bariatric surgery, obesity research, internal medicine, endocrinology, behavioral science, outcomes research, epidemiology, and other relevant fields to collaboratively plan and conduct studies that will ultimately lead to a better understanding of bariatric surgery and its impact on the health and well being of patients with extreme obesity.

The NIDDK has publications about weight control and bariatric surgery. For more information or to obtain copies, visit the NIDDK’s Weight-control Information Network at www.win.niddk.nih.gov.

[Top] [Next Article]


NIH Publication No. 10–4552
October 2009


dot

Digestive Diseases Home | Digestive Diseases A to Z | Statistics | Clinical Trials | Awareness and Prevention Series | Celiac Disease Awareness Campaign | Additional Resources | Order Publications | About Us | Información en Español |

Contact Us | NIDDK Health Information

The NDDIC is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

National Digestive Diseases Information Clearinghouse
2 Information Way
Bethesda, MD 20892–3570
Phone: 1–800–891–5389
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: nddic@info.niddk.nih.gov

Privacy | Disclaimer | Accessibility | PDF versions require the free Acrobat® Reader® software for viewing.
H H S logo - link to U. S. Department of Health and Human Services
NIH logo - link to the National Institute of Health
NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases